Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 3. Tobramycin

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 10, 2015, Pages 6646-6647

  Marchand, Sandrine ^a,b,c   Grégoire, Nicolas ^a,b   Brillault, Julien ^a,b   Lamarche, Isabelle ^a,b   Gobin, Patrice ^a,c   Couet, William ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOBRAMYCIN; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELIMINATION HALF-LIFE; EPITHELIAL LINING FLUID; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LUNG LAVAGE; MALE; MOLECULAR WEIGHT; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; TANDEM MASS SPECTROMETRY; ANIMAL; NEBULIZER; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHROMATOGRAPHY, LIQUID; MALE; NEBULIZERS AND VAPORIZERS; RATS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY; TOBRAMYCIN;

EID: 84942882503     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01647-15     Document Type: Article

References (8)

1. Falagas ME, Trigkidis KK, Vardakas KZ. 2015. Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: a systematic review. Int J Antimicrob Agents 45:221-233. http://dx.doi.org/10.1016/j.ijantimicag.2014.10.008.
2. Gontijo AV, Gregoire N, Lamarche I, Gobin P, Couet W, Marchand S. 2014. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. Colistin. Antimicrob Agents Chemother 58:3950-3956. http://dx.doi.org/10.1128/AAC.02819-14.
3. Gontijo AV, Brillault J, Gregoire N, Lamarche I, Gobin P, Couet W, Marchand S. 2014. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin. Antimicrob Agents Chemother 58:3942-3949. http://dx.doi.org/10.1128/AAC.02818-14.
4. Brillault J, De Castro WV, Couet W. 2010. Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model. Antimicrob Agents Chemother 54:543-545. http://dx.doi.org/10.1128/AAC.00733-09.
5. Brillault J, De Castro WV, Harnois T, Kitzis A, Olivier JC, Couet W. 2009. P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model. Antimicrob Agents Chemother 53:1457-1462. http://dx.doi.org/10.1128/AAC.01253-08.
6. Keevil BG, Lockhart SJ, Cooper DP. 2003. Determination of tobramycin in serum using liquid chromatography-tandem mass spectrometry and comparison with a fluorescence polarisation assay. J Chromatogr B Analyt Technol Biomed Life Sci 794:329-335. http://dx.doi.org/10.1016/S1570-0232 (03) 00492-6.
7. Marchand S, Gobin P, Brillault J, Baptista S, Adier C, Olivier JC, Mimoz O, Couet W. 2010. Aerosol therapy with colistin methanesulfonate: a biopharmaceutical issue illustrated in rats. Antimicrob Agents Chemother 54:3702-3707. http://dx.doi.org/10.1128/AAC.00411-10.
8. Yapa S W S, Li J, Porter C J H, Nation RL, Patel K, McIntosh MP. 2013. Population pharmacokinetics of colistin methanesulfonate in rats: achieving sustained lung concentrations of colistin for targeting respiratory infections. Antimicrob Agents Chemother 57:5087-5095. http://dx.doi.org/10.1128/AAC.01127-13.